sertraline has been researched along with Brain Vascular Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcon, E; Johnert, LC; Pimontel, MA; Reinlieb, ME; Roose, SP; Sneed, JR | 1 |
| Banerjee, S; Bingham, KS; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM | 1 |
| Barch, DM; D'Angelo, G; Doraiswamy, PM; Garcia, KS; Gersing, K; Krishnan, RR; MacFall, JR; McKinstry, RC; Pieper, CF; Sheline, YI; Steffens, DC; Taylor, W; Welsh-Boehmer, K; Welsh-Bohmer, K; Wilkins, C | 1 |
| Kontsevoĭ, VA; Medvedev, AV | 1 |
| Benedek, DM; Peterson, KA | 1 |
| Armstrong, S; Moseley, J; Peterson, KA | 1 |
| Arlinghaus, KA; Clearman, RR; George, MS; Kotrla, KJ; Nahas, Z | 1 |
1 review(s) available for sertraline and Brain Vascular Disorders
| Article | Year |
|---|---|
[Vascular depressions].
Topics: Adaptation, Psychological; Affective Symptoms; Asymptomatic Diseases; Brain; Catastrophization; Cerebral Arteries; Cerebrovascular Disorders; Depressive Disorder; Diagnosis, Differential; Humans; Prognosis; Psychotherapy; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
3 trial(s) available for sertraline and Brain Vascular Disorders
| Article | Year |
|---|---|
The external validity of MRI-defined vascular depression.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Cerebrovascular Disorders; Depressive Disorder; Double-Blind Method; Female; Geriatric Assessment; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Psychiatric Status Rating Scales; Psychomotor Performance; Reproducibility of Results; Sertraline; Sex Factors | 2013 |
Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cognition; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Executive Function; Humans; Mental Processes; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Reaction Time; Risk; Sertraline; Severity of Illness Index; Stroop Test; Treatment Outcome; Young Adult | 2015 |
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.
Topics: Age of Onset; Aged; Brain; Cerebrovascular Disorders; Cognition Disorders; Depressive Disorder, Major; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Proportional Hazards Models; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2010 |
3 other study(ies) available for sertraline and Brain Vascular Disorders
| Article | Year |
|---|---|
Sertraline for treatment of pathological crying.
Topics: 1-Naphthylamine; Aged; Cerebrovascular Disorders; Crying; Humans; Male; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Pathologic crying responsive to treatment with sertraline.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Cerebrovascular Disorders; Crying; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.
Topics: Adult; Affective Symptoms; Aged; Brain Injuries; Cerebrovascular Disorders; Crying; Fluoxetine; Humans; Laughter; Male; Middle Aged; Multiple Sclerosis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |